Can't answer that question. They may be perceived to have "first mover advantage", but I'd rather be 2nd to the finish line with better results. Big Pharma will back good results, not the speed of delivery of mediocre ones.
The HSV Vax Market, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.23 | $13.30 | $483.9K | 34.72K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $13.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.50 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |